Dr Reddy's Lab completes Phase 1 study of proposed arthritis drug

Dr Reddy's Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be used in the treatment of rheumatoid arthritis in adults.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/29SQNth
via IFTTT